Moderna sank nearly 10 percent in afternoon trading today, becoming the biggest decliner in the S&P 500 index. The sharp market reversal occurred in New York as cautious investors aggressively took profits ahead of highly anticipated late-stage clinical trial data for the company’s personalized cancer vaccine. The Cambridge, Massachusetts-based biotech firm lost more than 22 […]

The postModerna plummets as fearful investors rush to take profitsappeared first onRolling Out.